600 related articles for article (PubMed ID: 30378454)
1. Impact of treatment with liposomal bupivacaine on hospital costs, length of stay, and discharge status in patients undergoing total knee arthroplasty at high-use institutions.
Asche CV; Dagenais S; Kang A; Ren J; Maurer BT
J Med Econ; 2019 Jan; 22(1):85-94. PubMed ID: 30378454
[No Abstract] [Full Text] [Related]
2. Impact of liposomal bupivacaine on opioid use, hospital length of stay, discharge status, and hospitalization costs in patients undergoing total hip arthroplasty.
Asche CV; Dagenais S; Kang A; Ren J; Maurer BT
J Med Econ; 2019 Dec; 22(12):1253-1260. PubMed ID: 31161837
[No Abstract] [Full Text] [Related]
3. Efficacy of Liposomal Bupivacaine Infiltration on the Management of Total Knee Arthroplasty.
Sakamoto B; Keiser S; Meldrum R; Harker G; Freese A
JAMA Surg; 2017 Jan; 152(1):90-95. PubMed ID: 27732710
[TBL] [Abstract][Full Text] [Related]
4. Pain Control and Functional Milestones in Total Knee Arthroplasty: Liposomal Bupivacaine versus Femoral Nerve Block.
Yu S; Szulc A; Walton S; Bosco J; Iorio R
Clin Orthop Relat Res; 2017 Jan; 475(1):110-117. PubMed ID: 26883652
[TBL] [Abstract][Full Text] [Related]
5. Discontinuation of the liposomal delivery of bupivacaine has no effect on pain management after primary total knee arthroplasty : no effect on pain scores, opioid consumption, or functional status.
Feng JE; Ikwuazom CP; Mahure SA; Waren DP; Slover JD; Schwarzkopf RS; Long WJ; Macaulay WB
Bone Joint J; 2021 Jun; 103-B(6 Supple A):102-107. PubMed ID: 34053282
[TBL] [Abstract][Full Text] [Related]
6. Liposomal Bupivacaine Suspension Can Reduce Lengths of Stay and Improve Discharge Status of Patients Undergoing Total Knee Arthroplasty.
Chughtai M; Cherian JJ; Mistry JB; Elmallah RD; Bennett A; Mont MA
J Knee Surg; 2016 Apr; 29(3):224-7. PubMed ID: 26838971
[TBL] [Abstract][Full Text] [Related]
7. No Difference in Early Analgesia Between Liposomal Bupivacaine Injection and Intrathecal Morphine After TKA.
Barrington JW; Emerson RH; Lovald ST; Lombardi AV; Berend KR
Clin Orthop Relat Res; 2017 Jan; 475(1):94-105. PubMed ID: 27339124
[TBL] [Abstract][Full Text] [Related]
8. Liposomal bupivacaine reduces opioid consumption and length of stay in patients undergoing primary total hip arthroplasty.
VanWagner MJ; Krebs NM; Corser W; Johnson CN
Hip Int; 2019 May; 29(3):276-281. PubMed ID: 29808726
[TBL] [Abstract][Full Text] [Related]
9. Effects of Liposomal Bupivacaine With Adductor Canal Block on Pain and Functional Outcomes in Patients Undergoing Total Knee Arthroplasty.
Phillips J; Doshi A
Ann Pharmacother; 2016 Sep; 50(9):706-11. PubMed ID: 27289131
[TBL] [Abstract][Full Text] [Related]
10. Local Infiltration Analgesia With Liposomal Bupivacaine Improves Pain Scores and Reduces Opioid Use After Total Knee Arthroplasty: Results of a Randomized Controlled Trial.
Mont MA; Beaver WB; Dysart SH; Barrington JW; Del Gaizo DJ
J Arthroplasty; 2018 Jan; 33(1):90-96. PubMed ID: 28802777
[TBL] [Abstract][Full Text] [Related]
11. Cost-benefit evaluation of liposomal bupivacaine in the management of patients undergoing total knee arthroplasty.
Kirkness CS; Asche CV; Ren J; Kim M; Rainville EC
Am J Health Syst Pharm; 2016 May; 73(9):e247-54. PubMed ID: 27099332
[TBL] [Abstract][Full Text] [Related]
12. The Learning Curve Associated with the Administration of Intra-Articular Liposomal Bupivacaine for Total Knee Arthroplasty: A Pilot Study.
Khlopas A; Elmallah RK; Chughtai M; Yakubek GA; Faour M; Klika AK; Higuera CA; Molloy RM; Mont MA
Surg Technol Int; 2017 Feb; 30():314-320. PubMed ID: 28182826
[TBL] [Abstract][Full Text] [Related]
13. Is There a Benefit for Liposomal Bupivacaine Compared to a Traditional Periarticular Injection in Total Knee Arthroplasty Patients With a History of Chronic Opioid Use?
Schwarzkopf R; Drexler M; Ma MW; Schultz VM; Le KT; Rutenberg TF; Rinehart JB
J Arthroplasty; 2016 Aug; 31(8):1702-5. PubMed ID: 26897490
[TBL] [Abstract][Full Text] [Related]
14. Impact of long-acting local anesthesia on clinical and financial outcomes in laparoscopic colorectal surgery.
Keller DS; Pedraza R; Tahilramani RN; Flores-Gonzalez JR; Ibarra S; Haas EM
Am J Surg; 2017 Jul; 214(1):53-58. PubMed ID: 28624028
[TBL] [Abstract][Full Text] [Related]
15. Liposomal Bupivacaine Suspension, Can Reduce Length of Stay and Improve Discharge Status of Patients Undergoing Total Hip Arthroplasty.
Cherian JJ; Barrington J; Elmallah RK; Chughtai M; Mistry JB; Mont MA
Surg Technol Int; 2015 Nov; 27():235-9. PubMed ID: 26680403
[TBL] [Abstract][Full Text] [Related]
16. Role of Periarticular Liposomal Bupivacaine Infiltration in Patients Undergoing Total Knee Arthroplasty-A Meta-analysis of Comparative Trials.
Singh PM; Borle A; Trikha A; Michos L; Sinha A; Goudra B
J Arthroplasty; 2017 Feb; 32(2):675-688.e1. PubMed ID: 28029532
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of Liposomal Bupivacaine Compared with Multimodal Periarticular Injections for Postoperative Pain Control following Total Knee Arthroplasty.
Britten T; Hughes JD; Munoz Maldonado Y; Hitt KD
J Knee Surg; 2019 Oct; 32(10):979-983. PubMed ID: 30396201
[TBL] [Abstract][Full Text] [Related]
18. Which Clinical and Patient Factors Influence the National Economic Burden of Hospital Readmissions After Total Joint Arthroplasty?
Kurtz SM; Lau EC; Ong KL; Adler EM; Kolisek FR; Manley MT
Clin Orthop Relat Res; 2017 Dec; 475(12):2926-2937. PubMed ID: 28108823
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of Liposomal Bupivacaine versus Ropivacaine in Adductor Canal Block for Total Knee Arthroplasty.
Chen CM; Yun AG; Fan T
J Knee Surg; 2022 Jan; 35(1):96-103. PubMed ID: 32583397
[TBL] [Abstract][Full Text] [Related]
20. A Comparison of Pain Management Protocols Following Total Knee Arthroplasty: Femoral Nerve Block versus Periarticular Injection of Liposomal Bupivacaine with an Adductor Canal Block.
Sandhu S; Zadzilka JD; Nageeb E; Siqueira M; Klika AK; Molloy RM; Higuera CA
Surg Technol Int; 2019 May; 34():403-408. PubMed ID: 30388725
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
